Loading...
•
Jun 30, 2021
Health Catalyst Q2 2021 Earnings Report
Achieved strong performance, exceeding revenue and Adjusted EBITDA guidance, and reached positive quarterly Adjusted EBITDA for the first time since incorporation.
Key Takeaways
Health Catalyst reported strong second-quarter results, exceeding revenue and Adjusted EBITDA guidance. The company achieved positive quarterly Adjusted EBITDA for the first time and closed the acquisition of Twistle, which is expected to enhance the Population Health analytics application suite.
Achieved strong performance across the business in Q2 2021.
Exceeded the mid-point of quarterly guidance for both revenue and Adjusted EBITDA.
Achieved positive quarterly Adjusted EBITDA for the first time since the company’s incorporation.
Closed the acquisition of Twistle on July 1, 2021, to bolster the Population Health analytics application suite.
Health Catalyst
Health Catalyst
Health Catalyst Revenue by Segment
Revenue by Segment
Technology Revenue
CapyFin.comProfessional Services Revenue
CapyFin.com Forward Guidance
Health Catalyst provided revenue guidance between $59.4 million and $62.4 million and Adjusted EBITDA between $(7.5) million and $(5.5) million for Q3 2021. For the full year 2021, the company expects revenue between $236.7 million and $239.7 million and Adjusted EBITDA between $(12.5) million and $(10.5) million.
Positive Outlook
- Total revenue between $59.4 million and $62.4 million for Q3 2021
- Adjusted EBITDA between $(7.5) million and $(5.5) million for Q3 2021
- Total revenue between $236.7 million and $239.7 million for the full year of 2021
- Adjusted EBITDA between $(12.5) million and $(10.5) million for the full year of 2021
Revenue & Expenses
Visualization of income flow from segment revenue to net income